Dalriada is a petite molecule medication exploration organization backing worldwide pioneers through its TURN-KEY™ concept, where research and development is impeccably synchronized with commerce and intellectual property. With all research and development operations in Mississauga, Canada, we establish specialized teams in Medicinal Chemistry, Biology, and ADME to enable the most swift project progressions and value creation.